JAG2 and lung adenocarcinoma: In a mouse model of metastatic lung adenocarcinoma that coexpresses mutant KRAS (KRASG12D) and p53 (p53R172HΔG), we have shown that the NOTCH ligand Jagged2 was highly expressed by CD133-positive prometastatic lung adenocarcinoma cells [31].